Pressure BioSciences, Inc. announced the consolidation of its Boston area operations, uniting all of its personnel into a single, cutting-edge facility designed to accommodate expanded R&D capabilities, advanced equipment development and production, formulation services, and contract manufacturing based on its patented Ultra Shear Technology (UltraShear? or UST?) platform. The new building is currently being transformed into a state-of-the-art manufacturing facility. Strategically located in the Boston suburb of Canton, MA, the new facility will provide PBIO with a larger, more efficient space to continue its groundbreaking work in high pressure nanotechnology platform development ?

and UltraShear technology in particular. The state-of-the-art facility is to be equipped with the latest modern utilities and amenities, and will house dedicated areas for R&D, equipment production, formulation services, and product manufacturing. This move, consolidating R&D with all other departments of the Company, aims to streamline and achieve new production efficiencies, reduce costs, and foster innovation within a collaborative and dynamic work environment.

Key Features of the New Facility: Product Manufacturing Suites: PBIO is committed to meeting the increasing demand for its innovative nanoemulsion products, delivering breakthrough performance in fast and enhanced absorption of oil-soluble nutrients and therapeutics. The new facility will house several GMP-compliant contract manufacturing suites, equipped with the latest technology to ensure the efficient and precise production of high-quality products. Advanced R&D Laboratory: PBIO is investing in the development of a cutting-edge research and development laboratory, where its team of highly trained and experienced experts will continue to push the boundaries of high-pressure nanotechnology.

The laboratory will focus on developing groundbreaking solutions in nanoemulsions and other products for use in nutraceuticals, cosmeceuticals, pharmaceuticals, bioprocess, and other areas. State-of-the-Art Equipment Manufacturing: The facility features a dedicated space for the manufacturing of advanced equipment and components incorporating state-of-the-art materials and designs used in the production of nanoemulsions and other products. This will enable PBIO to expand production capacity in UltraShear equipment installations, while maintaining stringent quality control and ensuring the total reliability of its products.

Formulation Services: With a focus on providing comprehensive solutions, PBIO currently offers limited formulation services to its UltraShear clients. With the Canton site?s expanded space and equipment, the Company?s Formulation Services are expected to expand and grow significantly, as it collaborates closely with customers to develop customized formulations tailored to their specific needs and requirements, spanning a diversity of major market applications from nutraceuticals to cosmeceuticals/skincare, pharmaceuticals, food & beverages, and natural, organic agrochemicals. Demo Laboratory: A dedicated Demo Laboratory will showcase the Company?s cutting-edge UltraShear technology platform, allowing stakeholders to witness PBIO?s unique and far-reaching capabilities firsthand.